Les publications scientifiques

Afin d'apporter aux professionnels de la santé un soutien scientifique plus complet en matière d'immuno-hématologie et de transfusion animale, Alvedia met à votre disposition des articles et publications rédigés par les spécialistes mondiaux des domaines concernés.

 

  • Douglass K. Macintire, DVM, MS, DACVIM, DACVECC

    Anemia is common in critically ill cats. The origin may be either acute or chronic. The diagnostic workup for cats with acute anemia should include the following: evaluation of blood smear, slide agglutination test, complete blood count, new methylene blue stain for Heinz bodies, Coomb's test, blood typing, FeLV/FIV testing, chemistry panel, coagulation testing (if evidence of bleeding) and PCR for hemotropic mycoplasmas.

  • Urs Giger, PD Dr. med. vet. Dipl. ACVIM & ECVIM-CA, Dipl. ECVCP

    Since the early 80s the use of blood products in treating critically ill animals and supporting animals undergoing surgical and other procedures has tremendously increased. However, it should be noted that blood products are prepared from donor animals and represent a very limited resource not available in all situations, and as they are biologicals they bear the inherent risks to transmit infectious agents and cause other adverse transfusion reactions.

  • Urs Giger, Diplomate, ACVIM & ECVIM

    The identification of the various causes of feline anemia is a diagnostic challenge and has been reviewed in the previous chapter on Feline Anemia-a Diagnostic Challenge. Some of the therapeutic options for various specific diseases were also mentioned there and will be discussed here. However, this presentation will center on the supportive care with blood products.

  • Michael J. Day, BSc BVMS(Hons) PhD DSc DiplECVP FASM FRCPath FRCVS

    This presentation reviews aspects of the development and maturation of the canine and feline immune system in the in utero and neonatal period and the immunological disorders that are of importance during early life.

  • Urs Giger (Moderator), Philadelphia, PA; Beth Davidow, Seattle, WA; Anne S. Hale, Stockbridge, MI, Justine Lee, Urbana, IL; and others

    Transfusion therapy refers to the safe and effective replacement of blood or one of its components offering support for many critically ill, anemic and bleeding patients. Thereby, blood transfusions have become pivotal in any emergency and critical care setting which led to the large increase of blood product usage over the past two decades. The Transfusion Medicine Academic Awards, given by the NIH to 5 veterinary schools around 1990, have spurred research and greater emphasis on comparative transfusion medicine. Many novel blood banking techniques have recently been developed for use in companion animals.

  • Urs Giger, PD Dr. med. vet. Dipl. ACVIM & ECVIM-CA, Dipl. ECVCP

    Transfusion support is also critical for the feline patient, most commonly to correct anemia and less often bleeding. Nevertheless, blood transfusions are overall still less frequently administered to cats than dogs for a variety of reasons. Compared to canine transfusion medicine, cats can tolerate anemia better, they still get somewhat less medical attention, except for rodenticide toxicity and hepatopathies they bleed less severely, recruiting healthy donors is more difficult (occult heart disease, viral infections), blood collection requires sedation and special small bag collection systems, component therapy is less commonly practiced in clinics, cats have important naturally occurring alloantibodies and may experience life-threatening complications with a first transfusion, and the anemic cat is more sensitive to volume overload.

  • Elizabeth Rozanski, DVM, DACVECC, DACVIM (SA-IM)

    The platelet has recently undergone an expansion of interest, as understanding of their role in hemostasis, inflammation and healing is being further elucidated. Platelets are clearly important in primary hemostasis and a lack of platelets or platelet dysfunction is commonly clinically significant. The focus of this talk is two-fold- The first is to discuss the preparation and uses of platelet-rich plasma for management of thrombocytopenia or thrombocytopathia, while the second is to discuss the emerging role of platelet-rich plasma, platelet-rich gels, and platelet concentrates in supporting wound healing.

  • Sophie Adamantos, BVSc CertVA DipACVECC MRCVS

    The red blood cell membrane is covered proteins and complex carbohydrates and hence is antigenic. Patients recognise these foreign antigens as non-self when they receive a transfusion and stimulate antibody production.

  • Urs Giger, PD Dr. med. vet. Dipl. ACVIM & ECVIM-CA, Dipl. ECVCP

    In the emergency room and intensive care unit hemorrhage is a very common clinical problem in dogs. Depending on the (internal or external) site, acuteness, and degree of bleeding, dogs may have overt signs of hemorrhage, show specific organ failure (e.g. thoracic hemorrhage, hemoabdomen), and/or signs related to the systemic effects of hypovolemia, anemia and/or hypoproteinemia. Differentiating between normal and abnormal hemostasis by clinical and laboratory assessment is crucial; dogs with a bleeding tendency often exhibit recurrent and/or multiple sites of hemorrhage.

  • D. Hughes

    Since the first blood transfusion was carried out on a dog at Oxford University in 1666, the science of transfusion medicine has advanced a great deal. To perform transfusion medicine successfully, there must be an understanding not only of when and how to administer whole blood and its products but also of safe ways of obtaining and potentially storing these blood products. It is vital that blood used for transfusion is collected, processed, stored and used in a way that minimises the chance of any harm occurring to either the recipient or donor.

Cumulus Tag Cloud

Connexion utilisateur

Navigation